Menu
- Home
- Coronavirus
- Support
- Education
- Advocacy
- Research
×
Tag
Are you interested in the role health consumers play in planning and conducting health and medical research in Australia? Here’s your chance to have your say about how we can help shape the research that affects us.
Did you know children get arthritis, too? A new juvenile arthritis awareness campaign and a new research registry aim to improve the lives of young Australians with arthritis.
We joined the recent Australian Rheumatology Associations ASM to learn what the latest in research, therapies and best practice will mean for people with arthritis and related conditions.
A new Painaustralia report shows, since opioid regulations were tightened, 56.2 per cent of people with chronic pain have had their medication cut.
Global researchers are interested in learning how people with rheumatic disease make decisions regarding vaccines in light of their rheumatic disease.
What will the current COVID-19 vaccine candidates mean for Australians with autoimmune conditions? Can we take them? When will we get them?
If you have arthritis, back pain, osteoporosis or any other musculoskeletal condition or if you care for someone that does, Musculoskeletal Australia wants to hear from you.
Australians hospitalised with severe COVID-19 symptoms can now access the newly approved drug remdesivir (Veklury®) to help speed their recovery time.
Held virtually, the 2020 medical meeting from the European League Against Rheumatism shared important medical breakthroughs and updates about managing rheumatic conditions.
This commonly prescribed steroid might be lifesaving for critically ill coronavirus patients.